RCM
CRDF icon

RA Capital Management’s Cardiff Oncology CRDF Stock Holding History

RA Capital Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,290,000
Closed -$59.2M – 87
2020
Q4 		$59.2M Hold
3,290,000
– – 0.83% 36
2020
Q3 		$46.7M Buy
+3,290,000
New +$21.7M 0.85% 35
2015
Q2 		– Sell
-8,253
Closed -$4.05M – 62
2015
Q1 		$4.05M Buy
+8,253
New +$3.52M 0.4% 36

Other funds holding CRDF

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

RA Capital Management's CRDF Position: Q1 2021 in Review

RA Capital Management sold out of Cardiff Oncology (CRDF) in Q1 2021, closing a stake of 3,290,000 shares — an estimated $59.2M sold.

RA Capital Management first reported a position in CRDF in Q1 2015 and held it in 3 quarters. The position peaked at $59.2M in Q4 2020. 73 funds tracked by Wall St. Rank hold CRDF as of Q1 2021.

  • RA Capital Management reported no remaining Cardiff Oncology position as of Q1 2021 after selling out during the quarter.
  • RA Capital Management sold 3,290,000 Cardiff Oncology shares in Q1 2021, an estimated $59.2M.
  • RA Capital Management first reported a position in Cardiff Oncology in Q1 2015 and held it in 3 quarters.
  • RA Capital Management's Cardiff Oncology position peaked at $59.2M in Q4 2020.
  • 73 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2021.

Based on RA Capital Management's 13F filing for Q1 2021, filed 17 May 2021.